Rosett Max sold IMNM
April 2, 2026 · Form 4 insider transaction
Rosett Max sold 1,344 shares of Immunome, Inc. at $22.48 per share, a transaction worth $30.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,344
Price
$22.48
Total value
$30.2K
InsiderRosett Max
RoleOfficer
CompanyImmunome, Inc. (IMNM)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 2, 2026
Filing dateApril 3, 2026
Shares owned after54,037
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025.; The weighted average purchase price for the transaction report was $22.48, and the range of prices were between $22.45 and $22.56, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.